Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria

The effect of intraluminal acid and cholecystokinin (CCK) receptor blockade on the pancreatic secretory response was examined in rats. Blockade of gastric acid secretion by YM022 (CCK-B receptor antagonist) or famotidine (histamine-2 receptor antagonist) resulted in a significant suppression of case...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pancreas 1998-07, Vol.17 (1), p.57-64
Hauptverfasser: KUNO, M, SOGABE, H, ITO, H, MATSUO, T, SATOH, Y, MOTOYAMA, Y, TANAKA, H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 64
container_issue 1
container_start_page 57
container_title Pancreas
container_volume 17
creator KUNO, M
SOGABE, H
ITO, H
MATSUO, T
SATOH, Y
MOTOYAMA, Y
TANAKA, H
description The effect of intraluminal acid and cholecystokinin (CCK) receptor blockade on the pancreatic secretory response was examined in rats. Blockade of gastric acid secretion by YM022 (CCK-B receptor antagonist) or famotidine (histamine-2 receptor antagonist) resulted in a significant suppression of casein-stimulated pancreatic exocrine secretion as determined by juice volume and amylase secretion. Ligation of the gastric pylorus, which leads to complete prevention of gastric acid from entering the duodenum, also suppressed pancreatic exocrine secretion. FK480 (CCK-A receptor antagonist) inhibited pancreatic exocrine secretion dose dependently at doses of 0.01-1.0 mg/kg. When submaximal doses of FK480 and YM022 were treated concomitantly, pancreatic exocrine secretion was inhibited more profoundly than when treated solely. Hydrochloric acid (HCl; 0.05 N), injected into the duodenum, stimulated pancreatic exocrine secretion to a level comparable to that exhibited by intraduodenal casein. This effect of HCl was inhibited by FK480 (1.0 mg/kg) but not by YM022 (1.0 mg/kg). These findings suggest that inhibition of gastric acid secretion leads to the suppression of pancreatic exocrine secretion through mechanisms mediated by CCK-A receptors.
doi_str_mv 10.1097/00006676-199807000-00007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80005418</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80005418</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-820e8653845d6afa0f498c942561eafc8d123574996fcf953bd42acfebe0dee33</originalsourceid><addsrcrecordid>eNo9kMtKAzEUhoMoWi-PIGQhrhxNJvdlKd5QcKPrIZM5sZHppCZTsAvf3VRrsznkv5wDH0KYkmtKjLoh5UmpZEWN0USVX7WR1B6aUMFkxXWt99GEaC0qRpU6Qsc5fxBCFRPmEB2aUhY1naDv6ep9AcNoxxAHHD0e54DDMA9tGGNaY_Ae3Lgx7p64JlfY4tnsqZriBA6WJYJtKb_HIeTxCpcVSzu4BGWdw_AVXQoD4AxF-j3QrrF18z6m-bpLwZ6iA2_7DGfbeYLe7m5fZw_V88v942z6XDkm9VjpmoCWgmkuOmm9JZ4b7QyvhaRgvdMdrZlQ3BjpnTeCtR2vrfPQAukAGDtBl397lyl-riCPzSJkB31vB4ir3OjCTnCqS1D_BV2KOSfwzTKFhU3rhpJmQ775J9_syP9KqlTPtzdW7QK6XXGLuvgXW99mZ3ufCqiQd7Ga1Ywrwn4AOGmMFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80005418</pqid></control><display><type>article</type><title>Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>KUNO, M ; SOGABE, H ; ITO, H ; MATSUO, T ; SATOH, Y ; MOTOYAMA, Y ; TANAKA, H</creator><creatorcontrib>KUNO, M ; SOGABE, H ; ITO, H ; MATSUO, T ; SATOH, Y ; MOTOYAMA, Y ; TANAKA, H</creatorcontrib><description>The effect of intraluminal acid and cholecystokinin (CCK) receptor blockade on the pancreatic secretory response was examined in rats. Blockade of gastric acid secretion by YM022 (CCK-B receptor antagonist) or famotidine (histamine-2 receptor antagonist) resulted in a significant suppression of casein-stimulated pancreatic exocrine secretion as determined by juice volume and amylase secretion. Ligation of the gastric pylorus, which leads to complete prevention of gastric acid from entering the duodenum, also suppressed pancreatic exocrine secretion. FK480 (CCK-A receptor antagonist) inhibited pancreatic exocrine secretion dose dependently at doses of 0.01-1.0 mg/kg. When submaximal doses of FK480 and YM022 were treated concomitantly, pancreatic exocrine secretion was inhibited more profoundly than when treated solely. Hydrochloric acid (HCl; 0.05 N), injected into the duodenum, stimulated pancreatic exocrine secretion to a level comparable to that exhibited by intraduodenal casein. This effect of HCl was inhibited by FK480 (1.0 mg/kg) but not by YM022 (1.0 mg/kg). These findings suggest that inhibition of gastric acid secretion leads to the suppression of pancreatic exocrine secretion through mechanisms mediated by CCK-A receptors.</description><identifier>ISSN: 0885-3177</identifier><identifier>EISSN: 1536-4828</identifier><identifier>DOI: 10.1097/00006676-199807000-00007</identifier><identifier>PMID: 9667521</identifier><identifier>CODEN: PANCE4</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Achlorhydria - complications ; Amylases - drug effects ; Amylases - metabolism ; Animals ; Benzodiazepines - pharmacology ; Benzodiazepinones - pharmacology ; Biological and medical sciences ; Caseins - pharmacology ; Digestive system ; Dose-Response Relationship, Drug ; Duodenum - drug effects ; Famotidine - pharmacology ; Gastric Acid - metabolism ; Histamine H2 Antagonists - pharmacology ; Hormone Antagonists - pharmacology ; Hydrochloric Acid - pharmacology ; Indoles - pharmacology ; Male ; Medical sciences ; Pancreas - drug effects ; Pancreas - metabolism ; Pharmacology. Drug treatments ; Rats ; Rats, Wistar ; Receptor, Cholecystokinin A ; Receptors, Cholecystokinin - antagonists &amp; inhibitors</subject><ispartof>Pancreas, 1998-07, Vol.17 (1), p.57-64</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-820e8653845d6afa0f498c942561eafc8d123574996fcf953bd42acfebe0dee33</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>310,311,315,781,785,790,791,23934,23935,25144,27928,27929</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2323470$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9667521$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KUNO, M</creatorcontrib><creatorcontrib>SOGABE, H</creatorcontrib><creatorcontrib>ITO, H</creatorcontrib><creatorcontrib>MATSUO, T</creatorcontrib><creatorcontrib>SATOH, Y</creatorcontrib><creatorcontrib>MOTOYAMA, Y</creatorcontrib><creatorcontrib>TANAKA, H</creatorcontrib><title>Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria</title><title>Pancreas</title><addtitle>Pancreas</addtitle><description>The effect of intraluminal acid and cholecystokinin (CCK) receptor blockade on the pancreatic secretory response was examined in rats. Blockade of gastric acid secretion by YM022 (CCK-B receptor antagonist) or famotidine (histamine-2 receptor antagonist) resulted in a significant suppression of casein-stimulated pancreatic exocrine secretion as determined by juice volume and amylase secretion. Ligation of the gastric pylorus, which leads to complete prevention of gastric acid from entering the duodenum, also suppressed pancreatic exocrine secretion. FK480 (CCK-A receptor antagonist) inhibited pancreatic exocrine secretion dose dependently at doses of 0.01-1.0 mg/kg. When submaximal doses of FK480 and YM022 were treated concomitantly, pancreatic exocrine secretion was inhibited more profoundly than when treated solely. Hydrochloric acid (HCl; 0.05 N), injected into the duodenum, stimulated pancreatic exocrine secretion to a level comparable to that exhibited by intraduodenal casein. This effect of HCl was inhibited by FK480 (1.0 mg/kg) but not by YM022 (1.0 mg/kg). These findings suggest that inhibition of gastric acid secretion leads to the suppression of pancreatic exocrine secretion through mechanisms mediated by CCK-A receptors.</description><subject>Achlorhydria - complications</subject><subject>Amylases - drug effects</subject><subject>Amylases - metabolism</subject><subject>Animals</subject><subject>Benzodiazepines - pharmacology</subject><subject>Benzodiazepinones - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Caseins - pharmacology</subject><subject>Digestive system</subject><subject>Dose-Response Relationship, Drug</subject><subject>Duodenum - drug effects</subject><subject>Famotidine - pharmacology</subject><subject>Gastric Acid - metabolism</subject><subject>Histamine H2 Antagonists - pharmacology</subject><subject>Hormone Antagonists - pharmacology</subject><subject>Hydrochloric Acid - pharmacology</subject><subject>Indoles - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pancreas - drug effects</subject><subject>Pancreas - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptor, Cholecystokinin A</subject><subject>Receptors, Cholecystokinin - antagonists &amp; inhibitors</subject><issn>0885-3177</issn><issn>1536-4828</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMtKAzEUhoMoWi-PIGQhrhxNJvdlKd5QcKPrIZM5sZHppCZTsAvf3VRrsznkv5wDH0KYkmtKjLoh5UmpZEWN0USVX7WR1B6aUMFkxXWt99GEaC0qRpU6Qsc5fxBCFRPmEB2aUhY1naDv6ep9AcNoxxAHHD0e54DDMA9tGGNaY_Ae3Lgx7p64JlfY4tnsqZriBA6WJYJtKb_HIeTxCpcVSzu4BGWdw_AVXQoD4AxF-j3QrrF18z6m-bpLwZ6iA2_7DGfbeYLe7m5fZw_V88v942z6XDkm9VjpmoCWgmkuOmm9JZ4b7QyvhaRgvdMdrZlQ3BjpnTeCtR2vrfPQAukAGDtBl397lyl-riCPzSJkB31vB4ir3OjCTnCqS1D_BV2KOSfwzTKFhU3rhpJmQ775J9_syP9KqlTPtzdW7QK6XXGLuvgXW99mZ3ufCqiQd7Ga1Ywrwn4AOGmMFA</recordid><startdate>19980701</startdate><enddate>19980701</enddate><creator>KUNO, M</creator><creator>SOGABE, H</creator><creator>ITO, H</creator><creator>MATSUO, T</creator><creator>SATOH, Y</creator><creator>MOTOYAMA, Y</creator><creator>TANAKA, H</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980701</creationdate><title>Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria</title><author>KUNO, M ; SOGABE, H ; ITO, H ; MATSUO, T ; SATOH, Y ; MOTOYAMA, Y ; TANAKA, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-820e8653845d6afa0f498c942561eafc8d123574996fcf953bd42acfebe0dee33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Achlorhydria - complications</topic><topic>Amylases - drug effects</topic><topic>Amylases - metabolism</topic><topic>Animals</topic><topic>Benzodiazepines - pharmacology</topic><topic>Benzodiazepinones - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Caseins - pharmacology</topic><topic>Digestive system</topic><topic>Dose-Response Relationship, Drug</topic><topic>Duodenum - drug effects</topic><topic>Famotidine - pharmacology</topic><topic>Gastric Acid - metabolism</topic><topic>Histamine H2 Antagonists - pharmacology</topic><topic>Hormone Antagonists - pharmacology</topic><topic>Hydrochloric Acid - pharmacology</topic><topic>Indoles - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pancreas - drug effects</topic><topic>Pancreas - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptor, Cholecystokinin A</topic><topic>Receptors, Cholecystokinin - antagonists &amp; inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KUNO, M</creatorcontrib><creatorcontrib>SOGABE, H</creatorcontrib><creatorcontrib>ITO, H</creatorcontrib><creatorcontrib>MATSUO, T</creatorcontrib><creatorcontrib>SATOH, Y</creatorcontrib><creatorcontrib>MOTOYAMA, Y</creatorcontrib><creatorcontrib>TANAKA, H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pancreas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KUNO, M</au><au>SOGABE, H</au><au>ITO, H</au><au>MATSUO, T</au><au>SATOH, Y</au><au>MOTOYAMA, Y</au><au>TANAKA, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria</atitle><jtitle>Pancreas</jtitle><addtitle>Pancreas</addtitle><date>1998-07-01</date><risdate>1998</risdate><volume>17</volume><issue>1</issue><spage>57</spage><epage>64</epage><pages>57-64</pages><issn>0885-3177</issn><eissn>1536-4828</eissn><coden>PANCE4</coden><abstract>The effect of intraluminal acid and cholecystokinin (CCK) receptor blockade on the pancreatic secretory response was examined in rats. Blockade of gastric acid secretion by YM022 (CCK-B receptor antagonist) or famotidine (histamine-2 receptor antagonist) resulted in a significant suppression of casein-stimulated pancreatic exocrine secretion as determined by juice volume and amylase secretion. Ligation of the gastric pylorus, which leads to complete prevention of gastric acid from entering the duodenum, also suppressed pancreatic exocrine secretion. FK480 (CCK-A receptor antagonist) inhibited pancreatic exocrine secretion dose dependently at doses of 0.01-1.0 mg/kg. When submaximal doses of FK480 and YM022 were treated concomitantly, pancreatic exocrine secretion was inhibited more profoundly than when treated solely. Hydrochloric acid (HCl; 0.05 N), injected into the duodenum, stimulated pancreatic exocrine secretion to a level comparable to that exhibited by intraduodenal casein. This effect of HCl was inhibited by FK480 (1.0 mg/kg) but not by YM022 (1.0 mg/kg). These findings suggest that inhibition of gastric acid secretion leads to the suppression of pancreatic exocrine secretion through mechanisms mediated by CCK-A receptors.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>9667521</pmid><doi>10.1097/00006676-199807000-00007</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0885-3177
ispartof Pancreas, 1998-07, Vol.17 (1), p.57-64
issn 0885-3177
1536-4828
language eng
recordid cdi_proquest_miscellaneous_80005418
source MEDLINE; Journals@Ovid Complete
subjects Achlorhydria - complications
Amylases - drug effects
Amylases - metabolism
Animals
Benzodiazepines - pharmacology
Benzodiazepinones - pharmacology
Biological and medical sciences
Caseins - pharmacology
Digestive system
Dose-Response Relationship, Drug
Duodenum - drug effects
Famotidine - pharmacology
Gastric Acid - metabolism
Histamine H2 Antagonists - pharmacology
Hormone Antagonists - pharmacology
Hydrochloric Acid - pharmacology
Indoles - pharmacology
Male
Medical sciences
Pancreas - drug effects
Pancreas - metabolism
Pharmacology. Drug treatments
Rats
Rats, Wistar
Receptor, Cholecystokinin A
Receptors, Cholecystokinin - antagonists & inhibitors
title Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T13%3A49%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Augmentation%20of%20the%20inhibitory%20effect%20of%20FK480,%20a%20CCK-A%20receptor%20antagonist,%20on%20pancreatic%20exocrine%20secretion%20by%20achlorhydria&rft.jtitle=Pancreas&rft.au=KUNO,%20M&rft.date=1998-07-01&rft.volume=17&rft.issue=1&rft.spage=57&rft.epage=64&rft.pages=57-64&rft.issn=0885-3177&rft.eissn=1536-4828&rft.coden=PANCE4&rft_id=info:doi/10.1097/00006676-199807000-00007&rft_dat=%3Cproquest_cross%3E80005418%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80005418&rft_id=info:pmid/9667521&rfr_iscdi=true